{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:34:47Z","timestamp":1777358087352,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Study Design<\/jats:title>\n                    <jats:p>Review article.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite spinal cord pathology driving progressive disability in multiple sclerosis (MS), research has disproportionately focused on brain imaging. The clinical manifestations most relevant to MS patients\u2014mobility impairment, fatigue, and autonomic dysfunction\u2014derive primarily from spinal cord involvement, yet spinal cord metabolism remains virtually unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To quantify the research gap in spinal cord metabolic imaging and evaluate scientific rationale, technological readiness, and implementation potential for establishing this approach as a cornerstone of MS research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>I conducted a structured literature analysis of MS imaging publications (2014\u20132024) using defined PubMed searches, analyzed clinical trial registries for metabolic endpoints, and reviewed technological advances supporting clinical implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analysis revealed a striking 949:1 publication ratio between brain and spinal cord metabolic imaging studies, with only three spinal cord metabolic investigations versus 2847 brain imaging studies. Our 2014 study using \u00b9\u2078F-FDG PET during walking exercise demonstrated significantly reduced glucose uptake in MS patients\u2019 thoracic and lumbar spinal cord regions, correlating strongly with functional disability. Despite these promising findings and subsequent validation that spinal cord atrophy predicts disability progression better than brain measures, this research direction remained largely unexplored. Analysis of 387 MS clinical trials since 2014 revealed that while 73% include spinal cord structural measures, none incorporated metabolic assessments. Technological advances including total-body PET systems and AI-enhanced processing have addressed historical limitations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Spinal cord metabolic imaging represents a transformative but neglected research opportunity that could revolutionize MS biomarker development and precision medicine approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41393-025-01143-4","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T17:43:44Z","timestamp":1762796624000},"page":"642-647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Spinal cord metabolism in multiple sclerosis: a decade of missed opportunities and future directions"],"prefix":"10.1038","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2057-7793","authenticated-orcid":false,"given":"Thorsten","family":"Rudroff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"1143_CR1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26:1816\u201321.","journal-title":"Mult Scler"},{"key":"1143_CR2","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","volume":"389","author":"WJ Brownlee","year":"2017","unstructured":"Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017;389:1336\u201346.","journal-title":"Lancet"},{"key":"1143_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/jon.12553","volume":"28","author":"C Casserly","year":"2018","unstructured":"Casserly C, Seyman EE, Alcaide-Leon P, Guenette M, Lyons C, Sankar S, et al. Spinal cord atrophy in multiple sclerosis: a systematic review and meta-analysis. J Neuroimaging. 2018;28:556\u201386.","journal-title":"J Neuroimaging"},{"key":"1143_CR4","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444\u201352.","journal-title":"Neurology"},{"key":"1143_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1053\/j.sult.2016.07.007","volume":"38","author":"J Cohen-Adad","year":"2017","unstructured":"Cohen-Adad J. Functional magnetic resonance imaging of the spinal cord: current status and future developments. Semin Ultrasound CT MR. 2017;38:176\u201386.","journal-title":"Semin Ultrasound CT MR"},{"issue":"Suppl 3","key":"1143_CR6","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/sc.2014.130","volume":"52","author":"JH Kindred","year":"2014","unstructured":"Kindred JH, Koo PJ, Rudroff T. Glucose uptake of the spinal cord in patients with multiple sclerosis detected by \u00b9\u2078F-fluorodeoxyglucose PET\/CT after walking. Spinal Cord. 2014;52(Suppl 3):S11\u201313.","journal-title":"Spinal Cord"},{"key":"1143_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.46292\/sci2702-1","volume":"27","author":"R Rupp","year":"2021","unstructured":"Rupp R, Biering-S\u00f8rensen F, Burns SP, Graves DE, Guest J, Jones L, et al. International standards for neurological classification of spinal cord injury: revised 2019. Top Spinal Cord Inj Rehabil. 2021;27:1\u201322.","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"1143_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2967\/jnumed.116.184028","volume":"59","author":"SR Cherry","year":"2018","unstructured":"Cherry SR, Jones T, Karp JS, Qi J, Moses WW, Badawi RD. Total-body PET: maximizing sensitivity to create new opportunities for clinical research and patient care. J Nucl Med. 2018;59:3\u201312.","journal-title":"J Nucl Med"},{"key":"1143_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.neuroimage.2018.09.081","volume":"184","author":"C Gros","year":"2019","unstructured":"Gros C, De Leener B, Badji A, Maranzano J, Eden D, Dupont SM, et al. Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks. Neuroimage. 2019;184:901\u201315.","journal-title":"Neuroimage"},{"key":"1143_CR10","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.apmr.2013.05.015","volume":"94","author":"AE Latimer-Cheung","year":"2013","unstructured":"Latimer-Cheung AE, Martin Ginis KA, Hicks AL, Motl RW, Pilutti LA, Duggan M, et al. Development of evidence-informed physical activity guidelines for adults with multiple sclerosis. Arch Phys Med Rehabil. 2013;94:1829\u201336.e7.","journal-title":"Arch Phys Med Rehabil"},{"key":"1143_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in alzheimer\u2019s disease with pittsburgh compound-B. Ann Neurol. 2004;55:306\u201319.","journal-title":"Ann Neurol"},{"key":"1143_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","volume":"14","author":"VL Villemagne","year":"2015","unstructured":"Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC. Tau imaging: early progress and future directions. Lancet Neurol. 2015;14:114\u201324.","journal-title":"Lancet Neurol"},{"key":"1143_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ana.24018","volume":"75","author":"MP Sormani","year":"2014","unstructured":"Sormani MP, Arnold DL, De Stefano N. Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis. Ann Neurol. 2014;75:43\u20139.","journal-title":"Ann Neurol"},{"key":"1143_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abe5640","volume":"13","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wind K, Wiedemann T, Blume T, Shi Y, Briel N, et al. Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases. Sci Transl Med. 2021;13:eabe5640.","journal-title":"Sci Transl Med"},{"key":"1143_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1042\/BST20150058","volume":"43","author":"FE Turkheimer","year":"2015","unstructured":"Turkheimer FE, Rizzo G, Bloomfield PS, Howes O, Zanotti-Fregonara P, Bertoldo A, et al. The methodology of TSPO imaging with positron emission tomography. Biochem Soc Trans. 2015;43:586\u201392.","journal-title":"Biochem Soc Trans"},{"key":"1143_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(15)01314-8","volume":"387","author":"F Lublin","year":"2016","unstructured":"Lublin F, Miller DH, Freedman MS, Cree BAC, Wolinsky JS, Weiner H, et al. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet. 2016;387:1075\u201384.","journal-title":"Lancet"},{"key":"1143_CR17","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","volume":"133","author":"SL Hauser","year":"2020","unstructured":"Hauser SL, Cree BAC. Treatment of multiple sclerosis: a review. Am J Med. 2020;133:1380\u201390.e2.","journal-title":"Am J Med"},{"key":"1143_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autneu.2015.06.001","volume":"193","author":"JM Racosta","year":"2015","unstructured":"Racosta JM, Kimpinski K, Morrow SA, Kremenchutzky M. Autonomic dysfunction in multiple sclerosis. Auton Neurosci. 2015;193:1\u20136.","journal-title":"Auton Neurosci"},{"key":"1143_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrneurol.2012.136","volume":"8","author":"RW Motl","year":"2020","unstructured":"Motl RW, Pilutti LA. The benefits of exercise training in multiple sclerosis. Nature Reviews Neurology. 2020;8:487\u201397.","journal-title":"Nature Reviews Neurology"},{"key":"1143_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-020-00680-8","volume":"10","author":"M Aiello","year":"2020","unstructured":"Aiello M, Alfano V, Salvatore E, Cavaliere C, Picardi M, Della Pepa R, et al. [18F]FDG uptake of the normal spinal cord in PET\/MR imaging: comparison with PET\/CT imaging. EJNMMI Res. 2020;10:91.","journal-title":"EJNMMI Res"},{"key":"1143_CR21","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1073\/pnas.0610544104","volume":"104","author":"CG Radu","year":"2007","unstructured":"Radu CG, Shu CJ, Shelly SM, Phelps ME, Witte ON. Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2007;104:1937\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1143_CR22","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1007\/s00259-020-04786-y","volume":"47","author":"D Van Weehaeghe","year":"2020","unstructured":"Van Weehaeghe D, Devrome M, Schramm G, De Vocht J, Deckers W, Baete K, et al. Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics. Eur J Nucl Med Mol Imaging. 2020;47:2681\u201390.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1143_CR23","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s00259-012-2192-y","volume":"39","author":"K Uchida","year":"2012","unstructured":"Uchida K, Nakajima H, Okazawa H, Kimura H, Kudo T, Watanabe S, et al. Clinical significance of MRI\/(18)F-FDG PET fusion imaging of the spinal cord in patients with cervical compressive myelopathy. Eur J Nucl Med Mol Imaging. 2012;39:1528\u201337.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1143_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","volume":"86","author":"PJ Magistretti","year":"2015","unstructured":"Magistretti PJ, Allaman I. A cellular perspective on brain energy metabolism and functional imaging. Neuron. 2015;86:883\u2013901.","journal-title":"Neuron"},{"key":"1143_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","volume":"14","author":"DH Mahad","year":"2015","unstructured":"Mahad DH, Trapp BD, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015;14:183\u201393.","journal-title":"Lancet Neurol"},{"key":"1143_CR26","first-page":"19","volume":"13","author":"NW Lutz","year":"2007","unstructured":"Lutz NW, Viola A, Malikova I, Confort-Gouny S, Audoin B, Ranjeva JP, et al. Inflammatory multiple sclerosis patients display increased CSF lactate and decreased brain NAA. Mult Scler. 2007;13:19\u201324.","journal-title":"Mult Scler"},{"key":"1143_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jns.2008.07.032","volume":"275","author":"WT Regenold","year":"2008","unstructured":"Regenold WT, Phatak P, Makley MJ, Stone RD, Kling MA. Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression. J Neurol Sci. 2008;275:106\u201312.","journal-title":"J Neurol Sci"},{"key":"1143_CR28","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1212\/WNL.0000000000000905","volume":"83","author":"AM Dickens","year":"2014","unstructured":"Dickens AM, Larkin JR, Griffin JL, Cavey A, Matthews L, Turner MR, et al. A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis. Neurology. 2014;83:1492\u20139.","journal-title":"Neurology"},{"key":"1143_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1126\/science.aan4665","volume":"360","author":"MD Kornberg","year":"2018","unstructured":"Kornberg MD, Bhargava P, Kim PM, Putluri V, Snowman AM, Putluri N, et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science. 2018;360:449\u201353.","journal-title":"Science"},{"key":"1143_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3174\/ajnr.A1738","volume":"31","author":"AF Marliani","year":"2010","unstructured":"Marliani AF, Clementi V, Albini-Riccioli L, Agati R, Leonardi M. Quantitative cervical spinal cord 3T proton MR spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol. 2010;31:180\u20134.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1143_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molmed.2013.11.007","volume":"20","author":"ME Witte","year":"2014","unstructured":"Witte ME, Mahad DJ, Lassmann H, van Horssen J. Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis. Trends Mol Med. 2014;20:179\u201387.","journal-title":"Trends Mol Med"},{"key":"1143_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00019052-200206000-00003","volume":"15","author":"F Barkhof","year":"2002","unstructured":"Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol. 2002;15:239\u201345.","journal-title":"Curr Opin Neurol"},{"key":"1143_CR33","unstructured":"European Medicines Agency. Guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis. EMA\/CHMP\/771815\/2011 Rev. 2. 2015."},{"key":"1143_CR34","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2018.12917","volume":"320","author":"R Ossenkoppele","year":"2018","unstructured":"Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Sch\u00f6ll M, Strandberg O, et al. Discriminative accuracy of [18F]flortaucipir positron emission tomography for alzheimer disease vs other neurodegenerative disorders. JAMA. 2018;320:1151\u201362.","journal-title":"JAMA"},{"key":"1143_CR35","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","volume":"57","author":"S Minoshima","year":"2016","unstructured":"Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH, et al. SNMMI procedure standard\/EANM practice guideline for amyloid PET imaging of the brain 1.0. J Nucl Med. 2016;57:1316\u201322.","journal-title":"J Nucl Med"},{"key":"1143_CR36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S1474-4422(12)70059-5","volume":"11","author":"JA Cohen","year":"2012","unstructured":"Cohen JA, Reingold SC, Polman CH, Wolinsky JS. International advisory committee on clinical trials in multiple sclerosis. disability outcome measures in multiple sclerosis clinical trials: current status and future prospects. Lancet Neurol. 2012;11:467\u201376.","journal-title":"Lancet Neurol"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41393-025-01143-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-025-01143-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-025-01143-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:37:28Z","timestamp":1777354648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41393-025-01143-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1143"],"URL":"https:\/\/doi.org\/10.1038\/s41393-025-01143-4","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable. This narrative review is based on previously published literature and did not involve primary data collection from human participants or animals. The patient image included in this manuscript was previously published by the author in\n                      Spinal Cord\n                      [Reference 6] with appropriate informed consent obtained at the time of original publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}